Gaucher Disease: Clinical Trials

12 trials for Gaucher Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 unknown, 1 recruiting. 12 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 7, Unknown 4, Recruiting 1

Follow Gaucher Disease: new trials by email Literature Review of Gaucher Disease trials Research Report on Gaucher Disease

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)
Ambroxol - Gaucher Disease, Type 3
Not applicableCompletedAgyany Pharma LTD122025-03-012026-08-24
Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States (Project Searchlight)
Investigational procedure - Gaucher Disease
Not applicableCompletedSanofi132024-04-022024-11-19
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I
LY-M001 Injection - Gaucher Disease Type I
Not applicableRecruitingHe Huang32023-11-152025-02-14
Getting Global Rare Disease Insights Through Technology Study
Zamplo Digital Health Platform - Metabolic Disease, Fabry Disease
Not applicableUnknownM.A.G.I.C. Clinic LTD1502020-08-072021-04-08
Therapeutic Exercise to Treat Neuropathic Pain
Therapeutic Exercise - Gaucher Disease, Fabry Disease
Not applicableCompletedUniversidad de Zaragoza52019-05-022020-12-16
Eliglustat on Gaucher Disease Type IIIB
Eliglustat - Gaucher Disease, Type III
Not applicableCompletedNational Taiwan University Hospital42018-04-232022-09-15
Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs
quantitative chemical shift imaging (QCSI), Elelyso - Gaucher Disease, Type 1
Not applicableCompletedShaare Zedek Medical Center302017-01-012022-10-28
Miglustat on Gaucher Disease Type IIIB
Miglustat, ERT - Gaucher Disease
Not applicableUnknownNational Taiwan University Hospital192015-07-012019-03-29
Comparison of BMD Measurement by DEXA to BeamMed Speed-of-Sound Measurement at Forearm in Patients With Gaucher Disease
BeamMed Speed-of-Sound bone strength test at forearm - Gaucher Disease Type 1
Not applicableCompletedShaare Zedek Medical Center1002014-02-012014-11-19
Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan
Fibroscan - Fibrosis
Not applicableUnknownRambam Health Care Campus402013-08-012013-07-12
Identification of Undiagnosed Gaucher Disease
Enzyme analysis - Gaucher Disease
Not applicableUnknownBrigham and Women's Hospital1002012-08-012012-10-30
Cellular and Molecular Mechanisms Governing Bone Marrow Stem Cells in Gaucher Disease
Bone marrow and blood sampling - Gaucher Disease
Not applicableCompletedAssistance Publique - Hôpitaux de Paris302009-12-012014-05-23

Narrower conditions

Fabry Disease (2)  ·  Lysosomal Storage Diseases (2)  ·  Metabolic Diseases (2)  ·  Ataxia (1)  ·  Fibrosis (1)  ·  Glycogen Storage Disease Type II (1)  ·  Mitochondrial Diseases (1)  ·  Motor Activity (1)  ·  Myoclonus (1)  ·  Neurologic Manifestations (1)

Broader conditions

Brain Diseases (12)  ·  Brain Diseases, Metabolic (12)  ·  Brain Diseases, Metabolic, Inborn (12)  ·  Central Nervous System Diseases (12)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Genetic Diseases, Inborn (12)  ·  Lipid Metabolism Disorders (12)  ·  Lipid Metabolism, Inborn Errors (12)  ·  Lipidoses (12)  ·  Lysosomal Storage Diseases, Nervous System (12)  ·  Metabolism, Inborn Errors (12)  ·  Nervous System Diseases (12)  ·  Nutritional and Metabolic Diseases (12)  ·  Sphingolipidoses (12)  ·  Lysosomal Storage Diseases (10)

Interventions

Ambroxol (1)  ·  Blood Specimen Collection (1)  ·  Exercise Therapy (1)  ·  Restriction Mapping (1)  ·  eliglustat (1)  ·  miglustat (1)  ·  taliglucerase alfa (1)

Sponsors

National Taiwan University Hospital (2)  ·  Shaare Zedek Medical Center (2)  ·  Agyany Pharma LTD (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Brigham and Women's Hospital (1)  ·  He Huang (1)  ·  M.A.G.I.C. Clinic LTD (1)  ·  Rambam Health Care Campus (1)  ·  Sanofi (1)  ·  Universidad de Zaragoza (1)

Countries

Taiwan (2)  ·  United States (2)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  Pakistan (1)  ·  Spain (1)

Top investigators

Ari Zimran, MD (1)  ·  Ari Zimran, Prof. (1)  ·  Bertrabd Arnulf, MD (1)  ·  Hanna Rosenbaum (1)  ·  Huma Arshad Cheema, Prof. (1)  ·  Michael F Murray, MD (1)  ·  Ni-Chung Lee, M.D., Ph.D (1)  ·  Yin-Hsiu Chien, M.D., Ph.D. (1)

Results publications

PMID 14578207, PMID 1603628, PMID 17230068, PMID 23199589, PMID 23520473, PMID 24488939, PMID 24924293, PMID 25409372, PMID 26781431, PMID 28621801, PMID 29719368, PMID 30066229, PMID 30622983, PMID 32146279, PMID 33067633, PMID 35857660